12 Health Care Stocks Moving In Friday's After-Market Session

Comments
Loading...

Gainers

  • Nymox Pharmaceutical NYMX stock rose 30.0% to $0.42 during Friday's after-market session. The company's market cap stands at $38.4 million.
  • Renalytix RNLX shares moved upwards by 11.63% to $2.59. The company's market cap stands at $121.2 million.
  • Trxade Health MEDS shares increased by 10.86% to $0.38. The company's market cap stands at $3.5 million.
  • Bionomics BNOX stock moved upwards by 9.91% to $3.77. The company's market cap stands at $30.7 million.
  • NRX Pharmaceuticals NRXP stock increased by 8.93% to $0.73. The market value of their outstanding shares is at $49.4 million.
  • Gelesis Holdings GLS stock moved upwards by 8.33% to $0.26. The company's market cap stands at $19.0 million.

Losers

  • Infinity Pharmaceuticals INFI stock decreased by 7.6% to $0.18 during Friday's after-market session. The company's market cap stands at $16.1 million.
  • EUDA Health Holdings EUDA shares decreased by 7.43% to $1.87. Today's trading volume for this security ended up closing at 66.4K shares, which is 50.5 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $41.8 million.
  • Sunshine Biopharma SBFM stock declined by 7.24% to $0.79. The company's market cap stands at $17.8 million.
  • Gritstone Bio GRTS stock decreased by 6.11% to $2.0. The company's market cap stands at $166.7 million. As per the press release, Q4 earnings came out yesterday.
  • MorphoSys MOR stock fell 5.81% to $3.57. The company's market cap stands at $487.8 million.
  • Benitec Biopharma BNTC stock decreased by 5.41% to $0.24. The company's market cap stands at $6.8 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs

Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!